“…The A551P variant was identified in a patient presenting, in addition to AGel, another rare amyloidosis caused by a mutant of the transthyretin protein (ATTR-V122I) [30] , [37] . The patient did not have any clinical signs typical of AGel and overall A551P deposition appeared to be responsible for a mild phenotype.…”